MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Assembly Biosciences Inc

Open

SectorHealthcare

23.52 -3.72

Overview

Share price change

24h

Current

Min

23.04

Max

24.2

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+58.47% upside

News Sentiment

By Acuity

48%

52%

143 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Neutral Evidence

Assembly Biosciences Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 gru 2024, 15:25 UTC

Major Market Movers

Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding

19 gru 2024, 13:38 UTC

Major Market Movers

Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead

29 gru 2024, 08:00 UTC

Acquisitions, Mergers, Takeovers

Gilead Buys $20.1 Million of Assembly Biosciences Stock -- Barrons.com

19 gru 2024, 13:23 UTC

Major Market Movers

Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead

Peer Comparison

Price change

Assembly Biosciences Inc Forecast

Price Target

By TipRanks

58.47% upside

12 Months Forecast

Average 39 USD  58.47%

High 50 USD

Low 29 USD

Based on 4 Wall Street analysts offering 12 month price targets forAssembly Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

11.39 / 14.13Support & Resistance

Short Term

Neutral Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

143 / 371 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

$

help-icon Live chat